Greenwich LifeSciences, Inc.GLSINASDAQ
LOADING
|||
Operating Income Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year operating income growth rate
Latest
-3.18%
↑ 96% above average
Average (27q)
-81.92%
Historical baseline
Range
High:90.44%
Low:-1650.83%
Volatility
-2125.5%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | -3.18% |
| Q2 2025 | -23.26% |
| Q1 2025 | 59.40% |
| Q4 2024 | -196.23% |
| Q3 2024 | -2.54% |
| Q2 2024 | -4.90% |
| Q1 2024 | 10.54% |
| Q4 2023 | -13.31% |
| Q3 2023 | -43.20% |
| Q2 2023 | 22.01% |
| Q1 2023 | 22.58% |
| Q4 2022 | -21.47% |
| Q3 2022 | -208.16% |
| Q2 2022 | 61.12% |
| Q1 2022 | 16.32% |
| Q4 2021 | -174.29% |
| Q3 2021 | -15.03% |
| Q2 2021 | -25.45% |
| Q1 2021 | 47.86% |
| Q4 2020 | -348.43% |
| Q3 2020 | -22.07% |
| Q2 2020 | 13.98% |
| Q1 2020 | 27.31% |
| Q4 2019 | -0.16% |
| Q3 2019 | 87.10% |
| Q2 2019 | -1650.83% |
| Q1 2019 | 90.44% |
| Q4 2018 | 0.00% |